Blood Transfusion Diagnostics Market Players:
- Immucor, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Quotient Limited
- Beckman Coulter, Inc.
- DiaSorin S.p.A.
- BD (Becton, Dickinson, and Company)
- Ortho Clinical Diagnostics
- Grifols, S.A.
- Thermo Fisher Scientific Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of the blood transfusion diagnostics was over USD 5.64 Billion.
The market size for the blood transfusion diagnostics is projected to reach USD 10.49 Billion by the end of 2036 expanding at a CAGR of 6.4% during the forecast period i.e., between 2027-2036.
The North America blood transfusion diagnostics market will hold over 41% share by 2036, attributed to high accident rates and COVID-19 related blood supply disruptions.
Key players in the market include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
